Skip to main content
Thomas Price, MD, Obstetrics & Gynecology, Durham, NC

Thomas Michael Price MD

Reproductive Endocrinology & Infertility


Associate Professor, Obstetrics & Gynecology, Duke University School of Medicine

Join to View Full Profile
  • 5704 Fayetteville Rd# DukeDurham, NC 27713

  • Phone+1 919-572-4673

  • Fax+1 919-484-0461

Dr. Price is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterFellowship, Reproductive Endocrinology and Infertility, 1991
  • University of North Carolina Hospitals
    University of North Carolina HospitalsResidency, Obstetrics and Gynecology, 1985 - 1989
  • University of North Carolina at Chapel Hill School of Medicine
    University of North Carolina at Chapel Hill School of MedicineClass of 1984

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 2002 - 2023
  • SC State Medical License
    SC State Medical License 1991 - 2003
  • TX State Medical License
    TX State Medical License 1989 - 1994

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
  • Fellow (FACOG) American Congress of Obstetricians and Gynecologists

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • What Is Secondary Infertility?
    What Is Secondary Infertility?January 24th, 2023
  • Waiting to Conceive After Miscarriage May Not Be Needed
    Waiting to Conceive After Miscarriage May Not Be NeededDecember 1st, 2017
  • Determining 'Vascular Age' Is Best Predictor of Cardiovascular Risk with Hormone Therapy, Says Study
    Determining 'Vascular Age' Is Best Predictor of Cardiovascular Risk with Hormone Therapy, Says StudyAugust 5th, 2021

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: